Skip to main content
SpringerLink
Log in

Characterization of the Salts of a Cyclic RGB Peptide

  • Note
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. S. A. Mousa, J. M. Bozarth, M. S. Forsythe, W. Lorelli, M. J. Thoolen, N. Ramachandran, S. Jackson, W. De Grado, and T. M. Reilly. Antiplatelet Efficacy and Specificity of DMP 728, a Novel Platelet GPIIb/IIIa Receptor Antagonist. Cardiology 83:374–382 (1993).

    Google Scholar 

  2. S. A. Mousa, J. M. Bozarth, M. S. Forsythe, S. M. Jackson, A. Leamy, M. M. Diemer, R. P. Kapil, R. M. Knabb, M. C. Mayo, S. K. Pierce, W. F. De Grado, M. J. Thoolen, and T. M. Reilly. Antiplatelet and Antithrombotic Efficacy of DMP 728, a Novel Platelet GPIIb/IIIa Receptor Antagonist. Circulation 89:3–12 (1994).

    Google Scholar 

  3. R. Pytela, M. S. Pierschbacher, M. H. Ginsberg, E. F. Plow, and E. Ruoslahti. Platelet Membrane Glycoprotein IIb/IIIa: Member of a Family of RGD Specific Adhesion Receptors. Science 231:1559–1562 (1986).

    Google Scholar 

  4. D. R. Phillips, I. F. Charo, and R. M. Scarborough. GPIIb/IIIa: The Responsive Integrin. Cell 65:359–362 (1991).

    Google Scholar 

  5. S. A. Mousa, S. Flint, W. Lorelli, S. Hassell, J. Bozarth, W. De Grado, and T. M. Reilly. Intravenous Antiplatelet Efficacy and Safety of the Platelet GPIIb/IIIa Antagonist, DMP 728 in Anesthetized Dogs. Thromb. Res. 76:109–119 (1994).

    Google Scholar 

  6. S. M. Berge, L. D. Bighley, and D. C. Monkhouse. Pharmaceutical Salts. J. Pharm. Sci. 66:1–19 (1977).

    Google Scholar 

  7. G. C. Mazzenga and B. Berner. The Transdermal Delivery of Zwitterionic Drugs I: The Solubility of Zwitterion Salts. J. Controlled Release 16:77–88 (1991).

    Google Scholar 

  8. M. B. Maurin and M. A. Hussain. A Novel Isolation Method of a Stable Crystalline Salt of a Cyclic RGD Peptide Zwitterion. Pharm. Res. 12:1810–1812 (1995).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmacy R&D, The DuPont Merck Pharmaceutical Company, P. O. Box 80400, Wilmington, Delaware, 19880-0400

    Michael B. Maurin, Susan M. Rowe & Munir A. Hussain

  2. Chemical and Physical Sciences, The DuPont Merck Pharmaceutical Company, Wilmington, Delaware, 19880-0500

    Arlene Rockwell

  3. Corporate Center for Analytical Science, Central Research and Development, The DuPont Company, Wilmington, Delaware, 19880-0228

    C. M. Foris

Authors
  1. Michael B. Maurin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susan M. Rowe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Arlene Rockwell
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. M. Foris
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Munir A. Hussain
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maurin, M.B., Rowe, S.M., Rockwell, A. et al. Characterization of the Salts of a Cyclic RGB Peptide. Pharm Res 13, 481–484 (1996). https://doi.org/10.1023/A:1016021432262

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016021432262

Search

Navigation